Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease

Yah-Se K Abada1, Huu Phuc Nguyen, Bart Ellenbroek

  • 1Neuropharmacology, EVOTEC AG, Hamburg, Germany ; Brain Research Institute Dept. of Neuropharmacology, University of Bremen - FB 2, Bremen, Germany.

Plos One
|November 14, 2013
PubMed

Insights

Huntington disease (HD) rat models show cognitive deficits, including impaired associative memory and reversal learning, before motor symptom onset. These findings support BACHD rats as a valuable model for preclinical Huntington disease drug discovery.

Area of Science:

  • Neuroscience
  • Genetics
  • Animal Models

Background:

  • Huntington disease (HD) is a neurodegenerative disorder characterized by chorea and psychiatric symptoms.
  • Genetic hallmark of HD is expanded CAG repeats in the Huntingtin (HTT) gene.
  • Psychiatric symptoms in HD patients precede motor deficits.

Purpose of the Study:

  • To evaluate cognitive performance in BACHD rats, a model for Huntington disease.
  • To assess associative memory and reversal learning deficits in BACHD rats.
  • To determine the emergence of cognitive symptoms relative to motor deficits in BACHD rats.

Main Methods:

  • Cognitive tests including cross-maze for reversal learning and fear conditioning for associative memory were performed on BACHD and wild-type rats.
  • BACHD rats carrying the human full-length mutated HTT gene were tested across different age cohorts (2-12 months).
  • Pain sensitivity was assessed using a flinch-jump test to rule out confounding factors.

Main Results:

  • BACHD rats exhibited impaired reversal learning at 6 months.
  • Marked reduction in contextual fear conditioning was observed in BACHD rats from 4 to 12 months.
  • Impaired delay and trace fear conditioning were noted at 9 and 3 months, respectively, with no change in pain sensitivity.

Conclusions:

  • BACHD rats display significant associative memory deficits and potential reversal learning impairments.
  • Cognitive symptoms emerge in BACHD rats prior to motor symptom onset, mirroring human HD progression.
  • These findings suggest BACHD rats are a suitable model for preclinical Huntington disease research and drug discovery.

Related Concept Videos